Days At A Glance Speakers Session Type Search
Type

    12:00 -  20:00 
    Registration
    13:00 - 17:00 
    LOC Satellite Symposium: New kids on the block: Fat and Gut as Novel Targets in T2DM Treatment and Prevention
    13:00 - 14:50: Targeting adipose in the treatment of type 2 diabetes mellitus; 15:20 - 17:00: Hormones of GIT tract in the treatment of diabetes
    Room: Meeting Hall IV
    Chairs: Professor Martin Haluzik (Czech Republic) & Professor Michaela Diamant (The Netherlands)
    For more information about this symposium, including registration, please visit www.int3.cz
    LOC Satellite Symposium: New kids on the block: Fat and Gut as Novel Targets in T2DM Treatment and Prevention
    Can diabetes be treated by targeting adipose tissue? Lessons from animal models
    LOC Satellite Symposium: New kids on the block: Fat and Gut as Novel Targets in T2DM Treatment and Prevention
    Endocrine function of adipose tissue from bench to bedside
    LOC Satellite Symposium: New kids on the block: Fat and Gut as Novel Targets in T2DM Treatment and Prevention
    Thiazolidinediones in the treatment of type 2 diabetes mellitus in 2009
    LOC Satellite Symposium: New kids on the block: Fat and Gut as Novel Targets in T2DM Treatment and Prevention
    Side effects of thiazolidinediones: how important they really are?
    LOC Satellite Symposium: New kids on the block: Fat and Gut as Novel Targets in T2DM Treatment and Prevention
    Coffee Break & Light Refreshment
    LOC Satellite Symposium: New kids on the block: Fat and Gut as Novel Targets in T2DM Treatment and Prevention
    Incretin system and type 2 diabetes mellitus: GLP-1 agonists
    LOC Satellite Symposium: New kids on the block: Fat and Gut as Novel Targets in T2DM Treatment and Prevention
    DPP-4 agonists in the treatment of type 2 diabetes mellitus
    Helsinki, Finland
    LOC Satellite Symposium: New kids on the block: Fat and Gut as Novel Targets in T2DM Treatment and Prevention
    Cardiovascular effects of incretin-based therapies
    LOC Satellite Symposium: New kids on the block: Fat and Gut as Novel Targets in T2DM Treatment and Prevention
    Discussion & Closing
    17:30 - 18:45 
    Opening Ceremony: Geoffrey Harris Prize Lecture
    Room: Main Auditorium
    Chair: E. Nieschlag (Germany)
    Opening Ceremony: Geoffrey Harris Prize Lecture
    Transgenes and physiology in the Growth Hormone axis: a view from the portal
    18:45 - 19:30 
    Opening Ceremony: European Journal of Endocrinology Prize Lecture
    Room: Main Auditorium
    Chair: C. Strasburger - Editor-in-Chief of EJE (Germany)
    Opening Ceremony: European Journal of Endocrinology Prize Lecture
    Translating bone cell biology into clinical practice: target identified as RANK ligand
    19:30 -  22:00 
    Welcome Reception
    Room: Exhibition Hall

    07:00 -  20:00 
    Registration
    07:00 - 08:15 
    Satellite Symposia: Controversial Issues in Acromegaly
    Faculty presentations will be based on a pre-meeting e-poll
    Sponsored by Pfizer
    Room: Forum Hall
    Chair: Ezio Ghigo (Italy)
    08:30 -  10:00 
    Symposium 1: European Networks
    Main Auditorium
    Chairs: E. Nieschlag (Germany) & J. Christiansen (Denmark)
    S1.1
    Symposium 1: European Networks
    Endocrinology of the Ageing Male – The European Male Ageing Study (EMAS)
    S1.2
    Symposium 1: European Networks
    NECTAR - Network for Environmental Chemical Toxicants Affecting Reproduction
    S1.3
    Symposium 1: European Networks
    EUGOGO
    S1.4
    Symposium 1: European Networks
    The EuroDSD project and consortium
    S1.5
    Symposium 1: European Networks
    EurAdrenal
    S1.6
    Symposium 1: European Networks
    The European Registry on Cushing’s Syndrome (ERCUSYN) Database: First year experience
    08:30 -  10:00 
    Symposium 2: Endocrine aspects of the metabolic syndrome
    Room: Meeting Hall I
    Chairs: F. Casanueva (Spain) & TBC
    S2.1
    Symposium 2: Endocrine aspects of the metabolic syndrome
    Brain-adipose and brain-liver connections in the metabolic syndrome
    S2.2
    Symposium 2: Endocrine aspects of the metabolic syndrome
    Combined GH and IGF-1 treatment
    S2.3
    Symposium 2: Endocrine aspects of the metabolic syndrome
    Unacylated ghrelin: a metabolic hormone
    S2.4
    Symposium 2: Endocrine aspects of the metabolic syndrome
    Testosterone treatment in the metabolic syndrome
    08:30 -  10:00 
    Symposium 3: Bone Cell Biology
    Room: Panorama Hall
    Chairs: P. Broulik (Czech Republic) & J. Payer (Slovakia)
    S3.1
    Symposium 3: Bone Cell Biology
    Skeletal stem cells and mechanisms of bone formation
    S3.2
    Symposium 3: Bone Cell Biology
    Cross talks between Leptin and the skeleton
    S3.3
    Symposium 3: Bone Cell Biology
    The role of the hypothalamic-pituitary-thyroid axis in bone
    10:00 - 10:15 
    Coffee Break and Exhibition
    Room: Exhibition Hall
    10:15 -  11:00 
    Plenary Lecture 1
    Room: Main Auditorium
    Chairs: M. Alevizaki (Greece) & B. Jarzab (Poland)
    PL1
    Plenary Lecture 1
    Twenty years' experience with post-Chernobyl thyroid cancer
    11:00 -  11:15 
    Presidential Address
    Room: Main Auditorium
    11:15 -  12:45 
    Symposium 4: The Ageing Male
    Room: Main Auditorium
    Chairs: F. Wu ( UK) & G. Forti (Italy)
    S4.1
    Symposium 4: The Ageing Male
    Genetic aspects of aging in men
    S4.2
    Symposium 4: The Ageing Male
    Osteoporosis in the aging male
    S4.3
    Symposium 4: The Ageing Male
    The natural history of symptomatic androgen deficiency in men: Longitudinal results from the Massachussets Male Aging Study
    11:15 -  12:45 
    Symposium 5: Novel targets for thyroid cancer treatment
    Room: Forum Hall
    Chairs: F. Borson-Chazot (France) & J. Cap (Czech Republic)
    S5.1
    Symposium 5: Novel targets for thyroid cancer treatment
    Sodium Iodide Symporter
    S5.2
    Symposium 5: Novel targets for thyroid cancer treatment
    Molecular mechanisms in thyroid cancer
    S5.3
    Symposium 5: Novel targets for thyroid cancer treatment
    Tyrosine kinase inhibitors in thyroid cancer
    11:15 -  12:45 
    Symposium 6: Neuroendocrine control of reproduction
    Room: Meeting Hall I
    Chairs: J. Castano (Spain) & R. Millar (UK)
    S6.1
    Symposium 6: Neuroendocrine control of reproduction
    Sexual differentiation of hypothalamic Kiss1 neurons
    S6.2
    Symposium 6: Neuroendocrine control of reproduction
    KNDy (kisspeptin/neurokinin B/dynorphin) cells of the arcuate nucleus: a central node in the control of GnRH secretion
    S6.3
    Symposium 6: Neuroendocrine control of reproduction
    Consequences of Non-Classical ERα Signaling in Brain
    S6.4
    Symposium 6: Neuroendocrine control of reproduction
    Insulin regulation of reproductive brain: Rodent and human studies
    11:15 -  12:45 
    Oral Communications 1: Diabetes & Obesity
    Room: Panorama Hall
    Chairs: V. Hana (Czech Republic) & I. Konrade (Latvia)
    OC1.1
    Oral Communications 1: Diabetes & Obesity
    Role of newly identified immunosuppressive NK cells in autoimmunity
    OC1.2
    Oral Communications 1: Diabetes & Obesity
    Glucose insulinotropic peptide (GIP) secretion in Type 2 diabetic and obese non-diabetic persons examined by meal test
    OC1.3
    Oral Communications 1: Diabetes & Obesity
    NME7 - a new candidate gene for T2DM
    OC1.4
    Oral Communications 1: Diabetes & Obesity
    The effect of statin therapy on testosterone levels in subjects consulting for erectile dysfunction
    OC1.5
    Oral Communications 1: Diabetes & Obesity
    Role of PKA regulatory subunit R2B in murine and human adipocyte differentiation
    OC1.6
    Oral Communications 1: Diabetes & Obesity
    Variation in response to exercise in type 2 diabetes associated to VEGFA and PGC1-alfa expression
    13:00 -  14:30 
    Lunch & Exhibition
    ESE President Meets ESE Affiliated Society Presidents (Invitation Only - Meeting Hall V)
    Room: Exhibition Hall
    13:00 -  15:30 
    Poster session: Talk to me!
    13:00 -  14:30 
    Debate 1: When should we treat transsexualism / gender dysphoria?
    During Puberty: H. Delemarre-van de Waal (The Netherlands); After Puberty: G. T'Sjoen (Belgium)
    Room: Main Auditorium
    Chair: O. Hiort (Denmark)
    13:00 -  14:00 
    Meet the Expert 1: Delayed puberty in boys
    Room: Forum Hall
    E. Malecka-Tendera (Poland)
    13:00 -  14:00 
    Meet the Expert 2: Primary hyperaldosteronism
    Room: Meeting Hall I
    J. Widimsky (Czech Republic)
    13:00 -  14:00 
    Meet the Expert 3: The expanding phenotype of adult Turner syndrome
    Room: Panorama Hall
    C. Gravholt (Denmark)
    13:00 -  14:00 
    Meet the Expert 4: Disorders of sexual development (DSD)
    Room: Meeting Hall IV
    I. Hughes (UK)
    14:30 -  15:30 
    Meet the Expert 5: How do you choose your treatment in inoperable pancreatic NET?
    Room: Forum Hall
    B. Kos-Kudla (Poland)
    14:30 -  15:30 
    Meet the Expert 6: Management of Graves' ophthalmopathy
    Room: Meeting Hall I
    G. Krassas (Greece)
    14:30 -  15:30 
    Meet the Expert 7: Cushing's Syndrome
    Room: Panorama Hall
    M. Boscaro (Italy)
    14:30 -  15:30 
    Meet the Expert 8: Hyponatraemia: Diagnosis and novel treatments
    Room: Meeting Hall IV
    C. Thompson (Ireland)
    15:30 -  17:00 
    Symposium 7: Approaches to preservation of gonadal function after cancer therapy
    Room: Main Auditorium
    Chairs: S. Christin-Maitre (France) & A. Milewicz (Poland)
    S7.1
    Symposium 7: Approaches to preservation of gonadal function after cancer therapy
    Ovarian transplantation
    S7.2
    Symposium 7: Approaches to preservation of gonadal function after cancer therapy
    ART/IVF and cryopreservation
    S7.3
    Symposium 7: Approaches to preservation of gonadal function after cancer therapy
    Oocyte cryopreservation
    15:30 -  17:00 
    Symposium 8: Endocrine tumours: new genes and association with syndromes
    Room: Forum Hall
    Chairs: J. Bertherat (France) & K. Pacak (Czech Republic)
    S8.1
    Symposium 8: Endocrine tumours: new genes and association with syndromes
    Pituitary adenoma predisposition caused by AIP germline mutations
    S8.2
    Symposium 8: Endocrine tumours: new genes and association with syndromes
    New multiple endocrine neoplasias: endocrine tumours associated with gastrointestinal stromal tumours (GISTs)
    S8.3
    Symposium 8: Endocrine tumours: new genes and association with syndromes
    Update on familial pituitary tumours: from multiple endocrine neoplasia type 1 to familial isolated pituitary adenoma
    15:30 -  17:00 
    Symposium 9: The role of oxidative stress in the development of the metabolic syndrome
    Room: Meeting Hall I
    Chairs: A. Sjoholm (Sweden) & C. Meier (Switzerland)
    S9.1
    Symposium 9: The role of oxidative stress in the development of the metabolic syndrome
    Mitochondrial dysfunction and insulin resistance
    S9.2
    Symposium 9: The role of oxidative stress in the development of the metabolic syndrome
    Macrophage dysfunction and insulin resistance
    S9.3
    Symposium 9: The role of oxidative stress in the development of the metabolic syndrome
    Marked improvement of insulin resistance by reduced AGE intake; a non-pharmacologic, non-nutrient based intervention for type 2 diabetes
    15:30 -  17:00 
    Oral Communications 2: Thyroid
    Room: Panorama Hall
    Chairs: Z. Limanova (Czech Republic) & A. Gursoy (Turkey)
    OC2.1
    Oral Communications 2: Thyroid
    Calcitonin screening and pentagastrin testing: predictive value for diagnosis medullary carcinoma in nodular thyroid disease
    OC2.2
    Oral Communications 2: Thyroid
    Systemic sodium iodide symporter (NIS) gene transfer in hepatocellular carcinoma using EGF-receptor targeted non-viral gene delivery vectors
    OC2.3
    Oral Communications 2: Thyroid
    Allelic discrimination in the diagnosis of somatic BRAF V600E mutation on Fine-Needle Aspiration Biopsies
    OC2.4
    Oral Communications 2: Thyroid
    Polyglandular autoimmunity in autoimmune thyroid disease behaves differently from polyglandular autoimmunity in type 1 diabetes
    OC2.5
    Oral Communications 2: Thyroid
    Thyroid dysfunction related abnormalities in adiponectin and glucose metabolism before and after treatment
    OC2.6
    Oral Communications 2: Thyroid
    Percutaneous Laser Ablation (PLA) in non-functioning benign thyroid nodules: a 3-year follow-up study.
    17:00 -  17:15 
    Coffee Break and Exhibition
    Room: Exhibition Hall
    17:15 -  18:00 
    Plenary Lecture 2
    Room: Main Auditorium
    Chairs: J. Toppari (Finland) & E. Diamanti-Kanarakis (Greece)
    PL2
    Plenary Lecture 2
    Testicular dysgenesis and endocrine disruptors
    18:15 -  19:45 
    Satellite Symposium: Progress in the management of postmenopausal osteoporosis
    Sponsored by Amgen in collaboration with GSK
    Room: Panorama Hall
    Chairs: Peter Lakatos (Hungary) & Bente Langdahl (Denmark)
    Satellite Symposium: Progress in the management of postmenopausal osteoporosis
    Welcome from the chairs
    Satellite Symposium: Progress in the management of postmenopausal osteoporosis
    Burden of osteoporosis: why to treat and whom to treat?
    Satellite Symposium: Progress in the management of postmenopausal osteoporosis
    RANK Ligand - from molecular discovery to a novel understanding of osteoporosis
    Satellite Symposium: Progress in the management of postmenopausal osteoporosis
    RANK Ligand inhibition: the clinical evidence
    Satellite Symposium: Progress in the management of postmenopausal osteoporosis
    Discussion
    Satellite Symposium: Progress in the management of postmenopausal osteoporosis
    Close of meeting
    18:15 -  19:45 
    Satellite Symposium: Improving medical care thanks to multi-targeted therapies
    Sponsored by Ipsen
    Room: Forum Hall
    Chairs: Ann Klibanski (USA) & Ezio Ghigo (Italy)
    18:15 -  19:45 
    Satellite Symposium: Cardiovascular impact of therapies in endocrine diseases
    Sponsored by Merck Serono
    Room: Meeting Hall I
    Chair: Josef Marek (Czech Republic)
    Satellite Symposium: Cardiovascular impact of therapies in endocrine diseases
    Introduction
    Satellite Symposium: Cardiovascular impact of therapies in endocrine diseases
    Cardiovascular impact of GH therapy in adult Gh deficient patients
    Satellite Symposium: Cardiovascular impact of therapies in endocrine diseases
    Can early levothyroxine treatment reduce the cardiovascular risk in subclinical hypothyroidism
    Satellite Symposium: Cardiovascular impact of therapies in endocrine diseases
    Cardiovascular benefit of metformine in adults with type 2 diabetes
    Satellite Symposium: Cardiovascular impact of therapies in endocrine diseases
    Questions & Answers

    08:00 -  20:00 
    Registration
    08:45 -  10:15 
    Symposium 10: Novel aspects in the treatment of bone disease
    Room: Main Auditorium
    Chairs: D. Bassett (UK) & L. Hofbauer (Germany)
    S10.1
    Symposium 10: Novel aspects in the treatment of bone disease
    Principles of bone biology (the major pathways, RANKL, SOST, Wnt etc)
    S10.2
    Symposium 10: Novel aspects in the treatment of bone disease
    Preclinical and clinical effects of RANK ligand inhibition
    S10.3
    Symposium 10: Novel aspects in the treatment of bone disease
    Teriparatide and parathyroid hormone in the treatment of ostoporosis
    08:45 -  10:15 
    Symposium 11: Premature Ovarian Failure (POF)
    Room: Forum Hall
    Chairs: C. Andersen (Denmark) & J. Young (France)
    S11.1
    Symposium 11: Premature Ovarian Failure (POF)
    A pivotal role for NR5A1 in human reproductive processes
    S11.2
    Symposium 11: Premature Ovarian Failure (POF)
    Premature ovarian failure due to overactivation of primordial follicles in mice
    S11.3
    Symposium 11: Premature Ovarian Failure (POF)
    Ovarian AMH - Implications for the diagnosis of premature ovarian failure
    S11.4
    Symposium 11: Premature Ovarian Failure (POF)
    Genetic defects in ovarian growth/differentiation factors
    08:45 -  10:15 
    Symposium 12: Thyroid hormone metabolism and action: new developments
    Room: Meeting Hall I
    Chairs: J. Koehrle (Germany) & A. Aranda (Spain)
    S12.1
    Symposium 12: Thyroid hormone metabolism and action: new developments
    Thyroid hormone transporters
    S12.2
    Symposium 12: Thyroid hormone metabolism and action: new developments
    Life without T4 to T3 conversion
    S12.3
    Symposium 12: Thyroid hormone metabolism and action: new developments
    Thyroid hormone signalling in the heart
    S12.4
    Symposium 12: Thyroid hormone metabolism and action: new developments
    Significance of thyroid receptor alpha in metabolism
    08:45 -  10:15 
    Oral Communications 3: Pituitary
    Room: Panorama Hall
    Chairs: P. Vlcek (Czech Republic) & F. Kelestimur (Turkey)
    OC3.1
    Oral Communications 3: Pituitary
    Sgk1 effects on POMC transcription and ACTH release are opposite to those of glucocorticoids
    OC3.2
    Oral Communications 3: Pituitary
    Copeptin, an arginine vasopressin (AVP) marker, as a diagnostic aid in SIADH of cancer
    OC3.3
    Oral Communications 3: Pituitary
    Trauma severity, but not hypopituitarism, affects cognitive function after traumatic brain injury: a multi-center study in the Netherlands.
    OC3.4
    Oral Communications 3: Pituitary
    Influence of the d3-GH receptor polymorphism on the metabolic and biochemical phenotype of GH deficient adults at baseline and during short- and long-term rhGH replacement therapy.
    OC3.5
    Oral Communications 3: Pituitary
    Cortisol, but not ACTH/CRH, increases circulating ghrelin in man
    OC3.6
    Oral Communications 3: Pituitary
    Young Patients with Sporadic Macroadenomas as target population for AIP mutations screening
    10:15 -  11:00 
    Plenary Lecture 3
    Room: Main Auditorium
    Chairs: I. Huhtaniemi (UK) & M. Tena-Sempere (Spain)
    PL3
    Plenary Lecture 3
    Novel regulator of Gonadotropin
    11:00 -  11:15 
    Coffee Break and Exhibition
    Room: Exhibition Hall
    11:15 -  12:45 
    Symposium 13: The TSH Reference Range
    Room: Main Auditorium
    Chairs: P. Laurberg (Denmark) & I. Zosin (Romania)
    S13.1
    Symposium 13: The TSH Reference Range
    Determinants of the TSH reference range
    S13.2
    Symposium 13: The TSH Reference Range
    Health outcomes related to TSH values within the reference range
    S13.3
    Symposium 13: The TSH Reference Range
    A critical synopsis of current meta-analyses in the field of subclinical thyroid disease
    S13.4
    Symposium 13: The TSH Reference Range
    Solving the dilemma: what to do as a simple clinician
    11:15 -  12:45 
    Symposium 14: Novel actions of vitamin D
    Room: Forum Hall
    Chairs: M. Pfeifer (Slovenia) & M. Kraenzlin (Switzerland)
    S14.1
    Symposium 14: Novel actions of vitamin D
    Vitamin D and Diabetes
    S14.2
    Symposium 14: Novel actions of vitamin D
    Vitamin D and wnt signalling in colon cancer
    S14.3
    Symposium 14: Novel actions of vitamin D
    Vitamin D dependent anti-microbio pathways
    S14.4
    Symposium 14: Novel actions of vitamin D
    Vitamin D and differentiation of mesenchymal stem cells and osteoblasts
    11:15 -  12:45 
    Symposium 15: Wnt Signalling
    Room: Meeting Hall I
    Chairs: M. Tena-Sempere (Spain) & C. Stratakis (USA)
    S15.1
    Symposium 15: Wnt Signalling
    Wnt/Beta-Catenin Controls Stem Cells in Regeneration and Tumor Formation
    S15.2
    Symposium 15: Wnt Signalling
    Wnt signaling and the metabolic syndrome
    S15.3
    Symposium 15: Wnt Signalling
    Adipogenesis, diabetes and wnt signaling
    11:15 -  12:45 
    Oral Communications: Highlights 1
    Room: Panorama Hall
    Chairs: W. Arlt (UK) & A. Tsatsoulis (Greece)
    H1.1
    Oral Communications: Highlights 1
    PEX11beta deficiency impaired ossification by indirectly activating PPARgamma expression and diminishing Runx2 activity
    H1.2
    Oral Communications: Highlights 1
    Novel pathogenetic pathways of adrenocortical tumors revealed by meta-analysis of genomics data
    H1.3
    Oral Communications: Highlights 1
    Frequent phosphodiesterase 11a (pde11a4) gene mutations in patients with carney complex (cnc) due to prkar1a mutations and adrenal (ppnad) and sertoli cell tumors (lccsct): a digenic disorder?
    H1.4
    Oral Communications: Highlights 1
    Physiological rescue by functional complementation of mutated luteinising hormone receptors in transgenic mice
    H1.5
    Oral Communications: Highlights 1
    Different genes are involved in Pendred’s Syndrome and in Enlarged Vestibular Aqueduct Syndrome
    13:00 -  14:30 
    Lunch & Exhibition
    ESE President Meets New Members of the ESE (Invitation Only)
    Room: Exhibition Hall
    13:00 -  15:30 
    Poster session: Talk to me!
    13:00 -  14:30 
    Debate 2: This house believes that it is important to investigate patients with suspected primary hyperaldosteronism
    Room: Main Auditorium
    Chairs: M. Reincke (Germany) & J. Widimsky (Czech Republic)
    For: G. Rossi (Italy) & Against: K. Cruikshank (UK)
    13:00 -  14:00 
    Meet the Expert 9: Primary hyperparathyroidism: when to intervene?
    Room: Forum Hall
    C. Marcocci (Italy)
    13:00 -  14:00 
    Meet the Expert 10: High throughput mouse phenotyping with metabolomics
    Room: Meeting Hall I
    J. Adamski (Germany)
    13:00 -  14:00 
    Meet the Expert 11: Clinical approach to male infertility
    Room: Panorama Hall
    C. Krausz (Italy)
    13:00 -  14:00 
    Meet the Expert 12: The Zebrafish model
    Room: Meeting Hall IV
    V. Laudet (France)
    14:30 -  15:30 
    Meet the Expert 13: Subclinical Hypothyroidism: to treat or not to treat
    Room: Forum Hall
    V. Fadeyev (Russia)
    14:30 -  15:30 
    Meet the Expert 14: Practical management of Diabetes
    Room: Meeting Hall I
    J. Vassallo (Malta)
    14:30 -  15:30 
    Meet the Expert 15: Genetic and Genomic Studies in Endocrinology
    Room: Meeting Hall IV
    A. Uitterlinden (The Netherlands)
    14:30 -  15:30 
    Meet the Expert 16: Secondary Osteoporosis
    Room: Meeting Hall IV
    J. Stepan (Czech Republic)
    15:30 -  17:00 
    Symposium 16: Hot Topics in Pituitary Disease
    Room: Main Auditorium
    Chairs: C. Strasburger (Germany) & G. Lombardi (Italy)
    S16.1
    Symposium 16: Hot Topics in Pituitary Disease
    Pros and Cons of large scale screening of Cushing's syndrome
    S16.2
    Symposium 16: Hot Topics in Pituitary Disease
    The safety of dopamine agonists - Clinical perspective
    S16.3
    Symposium 16: Hot Topics in Pituitary Disease
    Problems with GH and IGF-1 assays: progress?
    15:30 -  17:00 
    Symposium 17: Genetic basis of infertility: Clinical studies and animal models
    Room: Forum Hall
    Chairs: P. Bouchard (France) & K. Liu (Sweden)
    S17.1
    Symposium 17: Genetic basis of infertility: Clinical studies and animal models
    Genetically modified mouse models for the analysis of reproductive disorders
    S17.2
    Symposium 17: Genetic basis of infertility: Clinical studies and animal models
    Neurokinin B signalling in human puberty
    S17.3
    Symposium 17: Genetic basis of infertility: Clinical studies and animal models
    Genetics of Kallmann syndrome
    15:30 -  17:00 
    Oral Communications 4: Adrenals
    Room: Meeting Hall I
    Chairs: S. Tsagarakis (Greece) & E. Husebye (Norway)
    OC4.1
    Oral Communications 4: Adrenals
    Subtype differentiation in primary hyperaldosteronism – evaluation of alternative algorithms avoiding a controversial gold standard
    OC4.2
    Oral Communications 4: Adrenals
    A mouse model with hyperaldosteronism carrying an ENU induced mutation on chromosome 9
    OC4.3
    Oral Communications 4: Adrenals
    Novel mutations in the glucocorticoid receptor gene : from familial bilateral adrenal hyperplasia to glucocorticoid receptor haploinsufficiency
    OC4.4
    Oral Communications 4: Adrenals
    Combined anticortisolic therapy by metyrapone, ketoconazole and mitotane: an alternative to adrenalectomy in severe Cushing’s syndrome
    OC4.5
    Oral Communications 4: Adrenals
    Effects of mitotane on testicular adrenal rest tumors size, sperm count and adrenal steroidogenesis in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
    OC4.6
    Oral Communications 4: Adrenals
    Serum Cortisol Predicts Increased Cardiovascular Mortality in Patients with Acute Coronary Syndrome
    15:30 -  17:00 
    Oral Communication Highlights 2
    Room: Panorama Hall
    Chairs: P. Beck-Peccoz (Italy) & P. Igaz (Hungary)
    H2.1
    Oral Communication Highlights 2
    The endocannabinoid action in the regulation of energy balance is mainly due to the CB1 receptor in the forebrain neurons
    H2.2
    Oral Communication Highlights 2
    Human recombinant GH replacement therapy in children with pseudohypoparathyroidism type Ia and GH deficiency: first study on the effect on growth
    H2.3
    Oral Communication Highlights 2
    Subtle cognitive impairments in patients with long-term cure of Cushing’s disease
    H2.4
    Oral Communication Highlights 2
    TAC3 and TACR3 “Knockouts” Cause Hypothalamic Congenital Hypogonadotropic Hypogonadism in Humans
    H2.5
    Oral Communication Highlights 2
    Effects of leptin administration on starvation-induced alterations in hepatic thyroid hormone metabolism in mice.
    17:00 -  17:15 
    Coffee Break and Exhibition
    Room: Exhibition Hall
    17:15 -  18:00 
    Plenary Lecture 4
    Room: Main Auditorium
    Chairs: W. Wiersinga (The Netherlands) & TBC
    PL4
    Plenary Lecture 4
    Thyronamines: Beyond T4 and T3
    18:15 -  19:45 
    Satellite Symposium: Understanding and management of primary hyperparathyroidism: anything new?
    Sponsored by Amgen
    Room: Panorama Hall
    Chair: John Bilezikian (USA)
    Satellite Symposium: Understanding and management of primary hyperparathyroidism: anything new?
    Welcome from the chair
    Satellite Symposium: Understanding and management of primary hyperparathyroidism: anything new?
    PHPT: prevalence and clinical presentation today
    Satellite Symposium: Understanding and management of primary hyperparathyroidism: anything new?
    Non-traditional features of modern PHPT
    Satellite Symposium: Understanding and management of primary hyperparathyroidism: anything new?
    Management of PHPT: What matters most?
    Satellite Symposium: Understanding and management of primary hyperparathyroidism: anything new?
    Close of meeting
    18:15 - 19:45 
    Satellite Symposium: Hypontraemia: is treatment necessary? An interactive forum.
    Sponsored by Otsuka
    Room: Meeting Hall I
    Chair: Paolo Beck-Peccoz
    Satellite Symposium: Hypontraemia: is treatment necessary? An interactive forum.
    Welcome and introduction
    Satellite Symposium: Hypontraemia: is treatment necessary? An interactive forum.
    Mild and moderate hyponatraemia - is treatment necessary?
    Satellite Symposium: Hypontraemia: is treatment necessary? An interactive forum.
    New approaches to the diagnosis of hyponatraemia
    Würzburg, Germany
    Satellite Symposium: Hypontraemia: is treatment necessary? An interactive forum.
    Considering new treatments in the management of hyponatraemia: Case study highlights
    Georgetown University, USA
    Satellite Symposium: Hypontraemia: is treatment necessary? An interactive forum.
    Questions and answers
    18:15 - 19:45 
    Satellite Symposium: Clinical insights on pituitary tumours
    Sponsored by Novartis
    Room: Forum Hall
    Chair: Michael Sheppard (UK)
    Satellite Symposium: Clinical insights on pituitary tumours
    A review of current practice and outcomes from patients with pituitary tumors
    Satellite Symposium: Clinical insights on pituitary tumours
    Achieving optimal outcomes for the patient with Acromegaly
    Satellite Symposium: Clinical insights on pituitary tumours
    Strategies for improving outcomes for the patient with Cushings disease
    20:30 - 23:59 
    ECE 2010 Informal Social Evening

    08:00 -  20:00 
    Registration
    08:45 -  10:15 
    Symposium 18: Diabetes in pregnancy
    Room: Forum Hall
    Chairs: E. Anastasiou (Greece) & R. Lehmann (Switzerland)
    S18.1
    Symposium 18: Diabetes in pregnancy
    Progress towards new criteria for diagnosis and classification of glucose metabolism during pregnancy
    S18.2
    Symposium 18: Diabetes in pregnancy
    New treatment modalities in diabetic pregnancy
    S18.3
    Symposium 18: Diabetes in pregnancy
    Gestational diabetes: High risk for future diabetes and cardiovascular disease
    08:45 -  10:15 
    Symposium 19: Fetal microchimerism as an explanation of disease
    Room: Meeting Hall I
    Chairs: L. Fugazzola (Italy) & U. Feldt-Rasmussen (Denmark)
    S19.1
    Symposium 19: Fetal microchimerism as an explanation of disease
    Microchimerism: Introduction and animal models
    S19.2
    Symposium 19: Fetal microchimerism as an explanation of disease
    Molecular microchimerism detection - its importance for non-invasive prenatal diagnosis and preeclampsia
    S19.3
    Symposium 19: Fetal microchimerism as an explanation of disease
    The role of microchimerism in autoimmune diseases
    08:45 -  10:15 
    Young Active Research (YAR) Symposium: The way to human metabolic diseases'
    Room: Panorama Hall
    Chairs: S. Schmid (Germany) & D.M. Schulte (Germany)
    Young Active Research (YAR) Symposium: The way to human metabolic diseases'
    Welcome & Introduction to YAR (DGE-ESE)
    Young Active Research (YAR) Symposium: The way to human metabolic diseases'
    Relationship between metabolic parameters and central dopaminergic activity in healthy men
    Young Active Research (YAR) Symposium: The way to human metabolic diseases'
    Novel syndromes of abnormal insulin sensitivity - lessons for common disease
    Edinburgh, UK
    Young Active Research (YAR) Symposium: The way to human metabolic diseases'
    The GG genotype of the G-11391A ADIPOQ poylmorphism might be a risk factor for development of type 2 diabetes mellitus in women
    Young Active Research (YAR) Symposium: The way to human metabolic diseases'
    Adipose tissue development and human metabolic disease
    Young Active Research (YAR) Symposium: The way to human metabolic diseases'
    Closing and invitation for the YAR meeting in 2010
    10:15 -  11:00 
    Plenary Lecture 5
    Room: Main Auditorium
    Chairs: M. Haluzik (Czech Republic) & A. Sjoholm (Sweden)
    PL5
    Plenary Lecture 5
    Discovery and relevance of the Incretin System
    Toronto, Canada
    11:00 -  11:15 
    Coffee Break and Exhibition
    Room: Exhibition Hall
    11:15 -  12:45 
    Symposium 20: The endocrine incidentaloma
    Room: Main Auditorium
    Chairs: J. Marek ( Czech Republic) & V. Popovic (Serbia)
    S20.1
    Symposium 20: The endocrine incidentaloma
    Thyroid incidentaloma. Endocrine incidentaloma
    S20.2
    Symposium 20: The endocrine incidentaloma
    Pituitary incidentalomas
    S20.3
    Symposium 20: The endocrine incidentaloma
    Adrenal Incidentalomas
    11:15 -  12:45 
    Symposium 21: The cardiometabolic interface
    Room: Forum Hall
    Chairs: V. Pirags (Latvia) & E. Fliers (The Netherlands)
    S21.1
    Symposium 21: The cardiometabolic interface
    Endothelial dysfunction in type 2 diabetes
    S21.2
    Symposium 21: The cardiometabolic interface
    Role of PPAR signalling in diabetic dyslipidemia
    S21.3
    Symposium 21: The cardiometabolic interface
    Mechanism and treatment of diabetic dyslipidemia
    11:15 -  12:45 
    Symposium 22: MicroRNAs in endocrinology
    Room: Meeting Hall I
    Chairs: S. Costagiola (Belgium) & J. Kruetzfeldt (Switzerland)
    S22.1
    Symposium 22: MicroRNAs in endocrinology
    MicroRNAs in biology
    S22.2
    Symposium 22: MicroRNAs in endocrinology
    MicroRNAs in thyroid cancer
    S22.3
    Symposium 22: MicroRNAs in endocrinology
    The role of microRNAs in hormone signaling
    11:15 - 12:45 
    Oral Communications 5: Reproduction & Thyroid
    Room: Panorama Hall
    Chairs: M. Simoni (Italy) & V. Zamrazil (Czech Republic)
    OC5.1
    Oral Communications 5: Reproduction & Thyroid
    Therapeutic concentrations of mitotane inhibit thyrotroph cell viability and TSH secretion in a mouse cell line model
    OC5.2
    Oral Communications 5: Reproduction & Thyroid
    The influence of cure of subclinical hyperthyroidism on diastolic diameters of heart chambers and cardiac index
    OC5.3
    Oral Communications 5: Reproduction & Thyroid
    Socio-economic factors and mortality in Turner syndrome – a registry study
    OC5.4
    Oral Communications 5: Reproduction & Thyroid
    One hormone, two functions - The chorionic gonadotropin in New World Monkeys
    OC5.5
    Oral Communications 5: Reproduction & Thyroid
    Predictive factors of intermittent ovarian function in Patients with Premature Ovarian Failure
    OC5.6
    Oral Communications 5: Reproduction & Thyroid
    Universal screening detects twice more thyroid disorders in early pregnancy than targeted high-risk case finding
    13:00 -  14:30 
    Lunch & Exhibition
    Room: Exhibition Hall
    13:00 -  15:30 
    Poster session: Talk to me!
    13:00 -  14:00 
    Meet the Expert 1: Delayed puberty in boys
    Room: Forum Hall
    E. Malecka-Tendera (Poland)
    13:00 -  14:00 
    Meet the Expert 2: Primary hyperaldosteronism
    Room: Meeting Hall I
    J. Widimsky (Czech Republic)
    13:00 -  14:00 
    Meet the Expert 3: Modern approach to the adult patient with Turner Syndrome
    Room: Panorama Hall
    C. Gravholt (Denmark)
    13:00 -  14:00 
    Meet the Expert 4: Disorders of sexual development (DSD)
    Room: Main Auditorium
    I. Hughes (UK)
    14:30 -  15:30 
    Meet the Expert 5: How do you choose your treatment in inoperable pancreatic NET?
    Room: Forum Hall
    B. Kos-Kudla (Poland)
    14:30 -  15:30 
    Meet the Expert 6: Management of Graves' ophthalmopathy
    Room: Meeting Hall I
    G. Krassas (Greece)
    14:30 -  15:30 
    Meet the Expert 7: Cushing's Syndrome
    Room: Panorama Hall
    M. Boscaro (Italy)
    14:30 -  15:30 
    Meet the Expert 8: Hyponatraemia: Diagnosis and novel treatments
    Room: Main Auditorium
    C. Thompson (Ireland)
    15:30 -  17:00 
    Symposium 23: Obesity: clinical manifestations and therapeutic intervention
    Room: Main Auditorium
    Chairs: A. Pfeifer (Germany) & A. Lewinski (Poland)
    S23.1
    Symposium 23: Obesity: clinical manifestations and therapeutic intervention
    Obesity: clinical manifestations and therapeutic. Does the choice of diet make any difference?
    S23.2
    Symposium 23: Obesity: clinical manifestations and therapeutic intervention
    Lifestyle intervention and pharmacologic approaches to weight loss
    S23.3
    Symposium 23: Obesity: clinical manifestations and therapeutic intervention
    Hormonal changes after bariatric surgery
    15:30 -  17:00 
    Symposium 24: Diagnosis and treatment of endocrine malignancies
    Room: Forum Hall
    Chairs: A. Tabarin (France) & G. Kaltsas (Greece)
    S24.1
    Symposium 24: Diagnosis and treatment of endocrine malignancies
    Malignant pheochromocytomas or paragangliomas
    S24.2
    Symposium 24: Diagnosis and treatment of endocrine malignancies
    Diagnosis and treatment of adrenocortical carcinomas
    S24.3
    Symposium 24: Diagnosis and treatment of endocrine malignancies
    Parathyroid carcinomas
    15:30 -  17:00 
    Symposium 25: Non-classical responses to hormones
    Room: Meeting Hall I
    Chairs: T. Scanlon (USA) & G. Brabant (UK)
    S25.1
    Symposium 25: Non-classical responses to hormones
    Rapid androgen action in epithelial and stromal cells.
    S25.2
    Symposium 25: Non-classical responses to hormones
    Non-classical actions of oestrogens in pancreas
    S25.3
    Symposium 25: Non-classical responses to hormones
    Protein kinase D as a modulator of aldosterone action in the kidney
    S25.4
    Symposium 25: Non-classical responses to hormones
    Extranuclear effects of thyroid hormones
    15:30 - 17:00 
    Oral Communications 6: Bone
    Room: Panorama Hall
    Chairs: A. Giustina (Italy) & J. Bollerslev (Norway)
    OC6.1
    Oral Communications 6: Bone
    A proteomic approch to study parathyroid glands
    OC6.2
    Oral Communications 6: Bone
    Association between serum osteocalcin and insulin sensitivity in primary hyperparathyroidism
    OC6.3
    Oral Communications 6: Bone
    Six novel mutations in 25-hydroxyvitamin D3 1alpha hydroxylase gene in patients with pseudovitamin D deficiency rickets.
    OC6.4
    Oral Communications 6: Bone
    Age-dependent features of bone mineral density changes in male rats with hyperthyroidism
    OC6.5
    Oral Communications 6: Bone
    The ratio of PTH as measured by third and second generation assays as a marker for parathyroid carcinoma.
    OC6.6
    Oral Communications 6: Bone
    Suppression of Circulating Fibroblast Growth Factor-23 by Cinacalcet in Patients with Primary Hyperparathyroidism
    17:00 -  17:15 
    Coffee Break and Exhibition
    Room: Exhibition Hall
    17:15 -  17:30 
    ESE Young Investigator Awards & Poster Prizes
    Sponsored by Novartis
    Room: Main Auditorium
    17:30 -  18:15 
    Plenary Lecture 6
    Room: Main Auditorium
    Chairs: I. Hughes (UK) & TBC
    PL6
    Plenary Lecture 6
    Sex and SOX
    18:30 -  20:00 
    Annual General Meeting of the European Society of Endocrinology (ESE)
    Room: Panorama Hall

    08:00 -  14:00 
    Registration
    08:00 -  09:30 
    Symposium 26: Adverse effects of drugs on thyroid
    Room: Forum Hall
    Chairs: M. Weissel (Austria) & L. Bartalena (Italy)
    S26.1
    Symposium 26: Adverse effects of drugs on thyroid
    Tyrosine kinase inhibitors and thyroid
    S26.2
    Symposium 26: Adverse effects of drugs on thyroid
    Treatment of amiodarone-induced thyrotoxicosis type 2: a RCT
    S26.3
    Symposium 26: Adverse effects of drugs on thyroid
    Interferons and thyroid
    08:00 -  09:30 
    Symposium 27: Multifaceted aspects of neuroprotection
    Room: Meeting Hall I
    Chairs: M. Hill (Czech Republic) & J. Castano (Spain)
    S27.1
    Symposium 27: Multifaceted aspects of neuroprotection
    Relationship between oestrogen and cholesterol in neuroprotection
    S27.2
    Symposium 27: Multifaceted aspects of neuroprotection
    Relationship between oestrogen and IGF system in neuroprotection
    S27.3
    Symposium 27: Multifaceted aspects of neuroprotection
    Progesterone and the nervous system
    S27.4
    Symposium 27: Multifaceted aspects of neuroprotection
    Oestrogen and corticotropin releasing hormone: Two hormones with different targets in neuroprotection
    08:00 -  09:30 
    Symposium 28: Hypothalamic networks and energy homeostasis
    Room: Panorama Hall
    Chairs: AJ van der Lely (The Netherlands) & TBC
    S28.1
    Symposium 28: Hypothalamic networks and energy homeostasis
    PYY and the regulation of appetite control
    S28.2
    Symposium 28: Hypothalamic networks and energy homeostasis
    Brain lipogenesis and the control of food intake: the lipostatic hypothesis revisited
    S28.3
    Symposium 28: Hypothalamic networks and energy homeostasis
    Hypothalamic plasticity and the central control of energy balance
    09:30 -  10:15 
    Plenary Lecture 7
    Room: Main Auditorium
    Chairs: A. Beckers (Belgium) & M. Krsek (Czech Republic)
    PL7
    Plenary Lecture 7
    New trends in diagnosis and localisation of (neuro) Endocrine Tumours
    10:15 -  11:15 
    Meet the Expert 9: Primary hyperparathyroidism: when to intervene?
    Room: Forum Hall
    C. Marcocci (Italy)
    10:15 -  11:15 
    Meet the Expert 10: High throughput mouse phenotyping with metabolomics
    Room: Meeting Hall I
    J. Adamski (Germany)
    10:15 -  11:15 
    Meet the Expert 11: Clinical approach to male infertility
    Room: Panorama Hall
    C. Krausz (Italy)
    10:15 -  11:15 
    Meet the Expert 12: The Zebrafish model
    Room: Main Auditorium
    V. Laudet (France)
    11:15 -  11:30 
    Coffee Break and Exhibition
    Room: Exhibition Hall
    11:30 -  12:30 
    Meet the Expert 13: Subclinical Hypothyroidism: to treat or not to treat
    Room: Forum Hall
    V. Fadeyev (Russia)
    11:30 -  12:30 
    Meet the Expert 14: Practical management of Diabetes
    Room: Meeting Hall I
    J. Vassallo (Malta)
    11:30 -  12:30 
    Meet the Expert 16: Secondary Osteoporosis
    Room: Panorama Hall
    J. Stepan (Czech Republic)
    12:30 -  13:15 
    Plenary Lecture 8
    Room: Main Auditorium
    Chairs: S. Damjanovic (Serbia) & C. Mantzoros (USA)
    PL8
    Plenary Lecture 8
    An update on the genetics of obesity
    13:15 -  13:30 
    Farewell and Invitation to Rotterdam
    Room: Main Auditorium
L. Aaltonen
Sun 25 15:30
S8.1
Symposium 8: Endocrine tumours: new genes and association with syndromes
Pituitary adenoma predisposition caused by AIP germline mutations
Silvano Adami
Sun 25 19:10
Satellite Symposium: Progress in the management of postmenopausal osteoporosis
RANK Ligand inhibition: the clinical evidence
Bruno Allolio
Würzburg, Germany
Mon 26 18:45
Satellite Symposium: Hypontraemia: is treatment necessary? An interactive forum.
New approaches to the diagnosis of hyponatraemia
Würzburg, Germany
C.Y. Anderson
Sun 25 15:30
S7.1
Symposium 7: Approaches to preservation of gonadal function after cancer therapy
Ovarian transplantation
B. Asvold
Mon 26 11:35
S13.2
Symposium 13: The TSH Reference Range
Health outcomes related to TSH values within the reference range
K. Badenhoop
Tue 27 09:45
S19.3
Symposium 19: Fetal microchimerism as an explanation of disease
The role of microchimerism in autoimmune diseases
A. Bashamboo
Mon 26 08:45
S11.1
Symposium 11: Premature Ovarian Failure (POF)
A pivotal role for NR5A1 in human reproductive processes
D. Bassett
Sun 25 09:30
S3.3
Symposium 3: Bone Cell Biology
The role of the hypothalamic-pituitary-thyroid axis in bone
R. Batterham
Wed 28 08:00
S28.1
Symposium 28: Hypothalamic networks and energy homeostasis
PYY and the regulation of appetite control
Paolo Beck-Peccoz
Mon 26 18:15
Satellite Symposium: Hypontraemia: is treatment necessary? An interactive forum.
Welcome and introduction
A. Beckers
Sun 25 16:30
S8.3
Symposium 8: Endocrine tumours: new genes and association with syndromes
Update on familial pituitary tumours: from multiple endocrine neoplasia type 1 to familial isolated pituitary adenoma
John Betteridge
Sat 24 13:50
LOC Satellite Symposium: New kids on the block: Fat and Gut as Novel Targets in T2DM Treatment and Prevention
Thiazolidinediones in the treatment of type 2 diabetes mellitus in 2009
M. Bidlingmaier
Mon 26 16:30
S16.3
Symposium 16: Hot Topics in Pituitary Disease
Problems with GH and IGF-1 assays: progress?
John Bilezikian
Mon 26 18:15
Satellite Symposium: Understanding and management of primary hyperparathyroidism: anything new?
Welcome from the chair
Mon 26 18:50
Satellite Symposium: Understanding and management of primary hyperparathyroidism: anything new?
Non-traditional features of modern PHPT
W. Birchmeier
Mon 26 11:15
S15.1
Symposium 15: Wnt Signalling
Wnt/Beta-Catenin Controls Stem Cells in Regeneration and Tumor Formation
Jens Bollerslev
Mon 26 18:20
Satellite Symposium: Understanding and management of primary hyperparathyroidism: anything new?
PHPT: prevalence and clinical presentation today
A. Borini
Sun 25 16:30
S7.3
Symposium 7: Approaches to preservation of gonadal function after cancer therapy
Oocyte cryopreservation
L. Brunerova
Tue 27 08:50
Young Active Research (YAR) Symposium: The way to human metabolic diseases'
Relationship between metabolic parameters and central dopaminergic activity in healthy men
G. Castoria
Tue 27 15:30
S25.1
Symposium 25: Non-classical responses to hormones
Rapid androgen action in epithelial and stromal cells.
A. Clement
Wed 28 09:00
S27.4
Symposium 27: Multifaceted aspects of neuroprotection
Oestrogen and corticotropin releasing hormone: Two hormones with different targets in neuroprotection
M. Coculescu
Tue 27 11:45
S20.2
Symposium 20: The endocrine incidentaloma
Pituitary incidentalomas
Anna Colao
Mon 26 18:45
Satellite Symposium: Clinical insights on pituitary tumours
Achieving optimal outcomes for the patient with Acromegaly
W. Colledge
Mon 26 15:30
S17.1
Symposium 17: Genetic basis of infertility: Clinical studies and animal models
Genetically modified mouse models for the analysis of reproductive disorders
G. Corona
Sun 25 09:30
S2.4
Symposium 2: Endocrine aspects of the metabolic syndrome
Testosterone treatment in the metabolic syndrome
Carolyn Deacon
Sat 24 16:20
LOC Satellite Symposium: New kids on the block: Fat and Gut as Novel Targets in T2DM Treatment and Prevention
Cardiovascular effects of incretin-based therapies
Michaela Diamant
Sat 24 15:20
LOC Satellite Symposium: New kids on the block: Fat and Gut as Novel Targets in T2DM Treatment and Prevention
Incretin system and type 2 diabetes mellitus: GLP-1 agonists
C. Dode
Mon 26 16:30
S17.3
Symposium 17: Genetic basis of infertility: Clinical studies and animal models
Genetics of Kallmann syndrome
Dr Daniel Drucker
Toronto, Canada
Tue 27 10:15
PL5
Plenary Lecture 5
Discovery and relevance of the Incretin System
Toronto, Canada
D. Dunger
Sun 25 08:50
S2.2
Symposium 2: Endocrine aspects of the metabolic syndrome
Combined GH and IGF-1 treatment
S. Eskes
Wed 28 08:30
S26.2
Symposium 26: Adverse effects of drugs on thyroid
Treatment of amiodarone-induced thyrotoxicosis type 2: a RCT
M. Fassnacht
Tue 27 16:00
S24.2
Symposium 24: Diagnosis and treatment of endocrine malignancies
Diagnosis and treatment of adrenocortical carcinomas
Richard Feelders
Mon 26 19:15
Satellite Symposium: Clinical insights on pituitary tumours
Strategies for improving outcomes for the patient with Cushings disease
U. Feldt-Rasmussen
Sun 25 18:45
Satellite Symposium: Cardiovascular impact of therapies in endocrine diseases
Can early levothyroxine treatment reduce the cardiovascular risk in subclinical hypothyroidism
S. Ferarri
Mon 26 09:15
S10.2
Symposium 10: Novel aspects in the treatment of bone disease
Preclinical and clinical effects of RANK ligand inhibition
E. Fliers
Sun 25 08:30
S2.1
Symposium 2: Endocrine aspects of the metabolic syndrome
Brain-adipose and brain-liver connections in the metabolic syndrome
E. Friesema
Mon 26 08:45
S12.1
Symposium 12: Thyroid hormone metabolism and action: new developments
Thyroid hormone transporters
V. Galton
Mon 26 09:05
S12.2
Symposium 12: Thyroid hormone metabolism and action: new developments
Life without T4 to T3 conversion
L.M. Garcia-Segura
Wed 28 08:20
S27.2
Symposium 27: Multifaceted aspects of neuroprotection
Relationship between oestrogen and IGF system in neuroprotection
Oksana Gavrilova
Sat 24 13:00
LOC Satellite Symposium: New kids on the block: Fat and Gut as Novel Targets in T2DM Treatment and Prevention
Can diabetes be treated by targeting adipose tissue? Lessons from animal models
R. Granata
Sun 25 09:10
S2.3
Symposium 2: Endocrine aspects of the metabolic syndrome
Unacylated ghrelin: a metabolic hormone
M. Guldstrand
Tue 27 16:30
S23.3
Symposium 23: Obesity: clinical manifestations and therapeutic intervention
Hormonal changes after bariatric surgery
Martin Haluzik
Sat 24 13:25
LOC Satellite Symposium: New kids on the block: Fat and Gut as Novel Targets in T2DM Treatment and Prevention
Endocrine function of adipose tissue from bench to bedside
M. Hewison
Mon 26 11:55
S14.3
Symposium 14: Novel actions of vitamin D
Vitamin D dependent anti-microbio pathways
O. Hiort
Sun 25 09:15
S1.4
Symposium 1: European Networks
The EuroDSD project and consortium
L. Hofbauer
Sat 24
Opening Ceremony: European Journal of Endocrinology Prize Lecture
Translating bone cell biology into clinical practice: target identified as RANK ligand
Lorenz Hofbauer
Sun 25 18:45
Satellite Symposium: Progress in the management of postmenopausal osteoporosis
RANK Ligand - from molecular discovery to a novel understanding of osteoporosis
W. Holzgreve
Tue 27 09:15
S19.2
Symposium 19: Fetal microchimerism as an explanation of disease
Molecular microchimerism detection - its importance for non-invasive prenatal diagnosis and preeclampsia
Philip Home
Sat 24 14:20
LOC Satellite Symposium: New kids on the block: Fat and Gut as Novel Targets in T2DM Treatment and Prevention
Side effects of thiazolidinediones: how important they really are?
T. Horvath
Wed 28 09:00
S28.3
Symposium 28: Hypothalamic networks and energy homeostasis
Hypothalamic plasticity and the central control of energy balance
I. Huhtaniemi
Sun 25 11:15
S4.1
Symposium 4: The Ageing Male
Genetic aspects of aging in men
E. Husebye
Sun 25 09:30
S1.5
Symposium 1: European Networks
EurAdrenal
S. Incerpi
Tue 27 16:30
S25.4
Symposium 25: Non-classical responses to hormones
Extranuclear effects of thyroid hormones
K. Jazdzewsji
Tue 27 11:45
S22.2
Symposium 22: MicroRNAs in endocrinology
MicroRNAs in thyroid cancer
M. Kassem
Sun 25 08:30
S3.1
Symposium 3: Bone Cell Biology
Skeletal stem cells and mechanisms of bone formation
A.S. Kauffman
Sun 25 11:15
S6.1
Symposium 6: Neuroendocrine control of reproduction
Sexual differentiation of hypothalamic Kiss1 neurons
A. Kautzky-Willer
Tue 27 08:45
S18.1
Symposium 18: Diabetes in pregnancy
Progress towards new criteria for diagnosis and classification of glucose metabolism during pregnancy
P. Kovanen
Sun 25 16:00
S9.2
Symposium 9: The role of oxidative stress in the development of the metabolic syndrome
Macrophage dysfunction and insulin resistance
M. Kraenzlin
Mon 26 09:45
S10.3
Symposium 10: Novel aspects in the treatment of bone disease
Teriparatide and parathyroid hormone in the treatment of ostoporosis
M. Laudes
Tue 27 09:40
Young Active Research (YAR) Symposium: The way to human metabolic diseases'
Adipose tissue development and human metabolic disease
H. Leeuwen
Mon 26 12:15
S14.4
Symposium 14: Novel actions of vitamin D
Vitamin D and differentiation of mesenchymal stem cells and osteoblasts
H. Leffers
Tue 27 11:15
S22.1
Symposium 22: MicroRNAs in endocrinology
MicroRNAs in biology
M.N. Lehman
Sun 25 11:35
S6.2
Symposium 6: Neuroendocrine control of reproduction
KNDy (kisspeptin/neurokinin B/dynorphin) cells of the arcuate nucleus: a central node in the control of GnRH secretion
J. Levine
Sun 25 11:55
S6.3
Symposium 6: Neuroendocrine control of reproduction
Consequences of Non-Classical ERα Signaling in Brain
K. Liu
Mon 26 09:05
S11.2
Symposium 11: Premature Ovarian Failure (POF)
Premature ovarian failure due to overactivation of primordial follicles in mice
M. Lopex
Wed 28 08:30
S28.2
Symposium 28: Hypothalamic networks and energy homeostasis
Brain lipogenesis and the control of food intake: the lipostatic hypothesis revisited
R. Lovell-Badge
Tue 27 17:30
PL6
Plenary Lecture 6
Sex and SOX
C. Mantzoros
Tue 27 15:30
S23.1
Symposium 23: Obesity: clinical manifestations and therapeutic intervention
Obesity: clinical manifestations and therapeutic. Does the choice of diet make any difference?
Claudio Marcocci
Mon 26 19:20
Satellite Symposium: Understanding and management of primary hyperparathyroidism: anything new?
Management of PHPT: What matters most?
Josef Marek
Sun 25 18:15
Satellite Symposium: Cardiovascular impact of therapies in endocrine diseases
Introduction
S. Mariotti
Mon 26 12:15
S13.4
Symposium 13: The TSH Reference Range
Solving the dilemma: what to do as a simple clinician
C. Mattieu
Mon 26 11:15
S14.1
Symposium 14: Novel actions of vitamin D
Vitamin D and Diabetes
Eugene McCloskey
Sun 25 18:20
Satellite Symposium: Progress in the management of postmenopausal osteoporosis
Burden of osteoporosis: why to treat and whom to treat?
R. Millar
Mon 26 10:15
PL3
Plenary Lecture 3
Novel regulator of Gonadotropin
J. Mittag
Mon 26 09:45
S12.4
Symposium 12: Thyroid hormone metabolism and action: new developments
Significance of thyroid receptor alpha in metabolism
A. Morris
Sun 25 19:05
Satellite Symposium: Cardiovascular impact of therapies in endocrine diseases
Cardiovascular benefit of metformine in adults with type 2 diabetes
A. Munoz
Mon 26 11:35
S14.2
Symposium 14: Novel actions of vitamin D
Vitamin D and wnt signalling in colon cancer
A. Nadal
Tue 27 15:50
S25.2
Symposium 25: Non-classical responses to hormones
Non-classical actions of oestrogens in pancreas
T. Nystrom
Tue 27 11:15
S21.1
Symposium 21: The cardiometabolic interface
Endothelial dysfunction in type 2 diabetes
K. O'Donoghue
Tue 27 08:45
S19.1
Symposium 19: Fetal microchimerism as an explanation of disease
Microchimerism: Introduction and animal models
S. O'Rahilly
Wed 28 12:30
PL8
Plenary Lecture 8
An update on the genetics of obesity
K. Pacak
Wed 28 09:30
PL7
Plenary Lecture 7
New trends in diagnosis and localisation of (neuro) Endocrine Tumours
A. Pereira
Mon 26 16:00
S16.2
Symposium 16: Hot Topics in Pituitary Disease
The safety of dopamine agonists - Clinical perspective
A. Peri
Wed 28 08:00
S27.1
Symposium 27: Multifaceted aspects of neuroprotection
Relationship between oestrogen and cholesterol in neuroprotection
L. Persani
Mon 26 09:45
S11.4
Symposium 11: Premature Ovarian Failure (POF)
Genetic defects in ovarian growth/differentiation factors
D. Picard
Tue 27 12:15
S22.3
Symposium 22: MicroRNAs in endocrinology
The role of microRNAs in hormone signaling
P-F. Plouin
Tue 27 15:30
S24.1
Symposium 24: Diagnosis and treatment of endocrine malignancies
Malignant pheochromocytomas or paragangliomas
J. Polosak
Tue 27 09:30
Young Active Research (YAR) Symposium: The way to human metabolic diseases'
The GG genotype of the G-11391A ADIPOQ poylmorphism might be a risk factor for development of type 2 diabetes mellitus in women
F. Pralong
Sun 25 12:15
S6.4
Symposium 6: Neuroendocrine control of reproduction
Insulin regulation of reproductive brain: Rodent and human studies
I. Robinson
Sat 24
Opening Ceremony: Geoffrey Harris Prize Lecture
Transgenes and physiology in the Growth Hormone axis: a view from the portal
M. Roden
Sun 25 15:30
S9.1
Symposium 9: The role of oxidative stress in the development of the metabolic syndrome
Mitochondrial dysfunction and insulin resistance
P. Rodien
Wed 28 08:00
S26.1
Symposium 26: Adverse effects of drugs on thyroid
Tyrosine kinase inhibitors and thyroid
G. Russell
Mon 26 08:45
S10.1
Symposium 10: Novel aspects in the treatment of bone disease
Principles of bone biology (the major pathways, RANKL, SOST, Wnt etc)
L. Sacca
Sun 25 18:25
Satellite Symposium: Cardiovascular impact of therapies in endocrine diseases
Cardiovascular impact of GH therapy in adult Gh deficient patients
M. Santoro
Sun 25 11:45
S5.2
Symposium 5: Novel targets for thyroid cancer treatment
Molecular mechanisms in thyroid cancer
T. Scanlon
Mon 26 17:15
PL4
Plenary Lecture 4
Thyronamines: Beyond T4 and T3
G. Schernthaner
Tue 27 09:45
S18.3
Symposium 18: Diabetes in pregnancy
Gestational diabetes: High risk for future diabetes and cardiovascular disease
S. Schinner
Mon 26 11:45
S15.2
Symposium 15: Wnt Signalling
Wnt signaling and the metabolic syndrome
S. Schmid
Tue 27 08:45
Young Active Research (YAR) Symposium: The way to human metabolic diseases'
Welcome & Introduction to YAR (DGE-ESE)
D. Schulte
Tue 27 10:10
Young Active Research (YAR) Symposium: The way to human metabolic diseases'
Closing and invitation for the YAR meeting in 2010
M. Schumacher
Wed 28 08:40
S27.3
Symposium 27: Multifaceted aspects of neuroprotection
Progesterone and the nervous system
Robert Semple
Edinburgh, UK
Tue 27 09:00
Young Active Research (YAR) Symposium: The way to human metabolic diseases'
Novel syndromes of abnormal insulin sensitivity - lessons for common disease
Edinburgh, UK
J. Sethi
Mon 26 12:15
S15.3
Symposium 15: Wnt Signalling
Adipogenesis, diabetes and wnt signaling
Michael Sheppard
Mon 26 18:15
Satellite Symposium: Clinical insights on pituitary tumours
A review of current practice and outcomes from patients with pituitary tumors
W. Simonides
Mon 26 09:25
S12.3
Symposium 12: Thyroid hormone metabolism and action: new developments
Thyroid hormone signalling in the heart
N. Skakkebaek
Sun 25 17:15
PL2
Plenary Lecture 2
Testicular dysgenesis and endocrine disruptors
J. Smit
Sun 25 12:15
S5.3
Symposium 5: Novel targets for thyroid cancer treatment
Tyrosine kinase inhibitors in thyroid cancer
C. Spitzweg
Sun 25 11:15
S5.1
Symposium 5: Novel targets for thyroid cancer treatment
Sodium Iodide Symporter
B. Staels
Tue 27 11:45
S21.2
Symposium 21: The cardiometabolic interface
Role of PPAR signalling in diabetic dyslipidemia
C. Stratakis
Sun 25 16:00
S8.2
Symposium 8: Endocrine tumours: new genes and association with syndromes
New multiple endocrine neoplasias: endocrine tumours associated with gastrointestinal stromal tumours (GISTs)
B. Szende
Tue 27 16:30
S24.3
Symposium 24: Diagnosis and treatment of endocrine malignancies
Parathyroid carcinomas
A. Tabarin
Mon 26 15:30
S16.1
Symposium 16: Hot Topics in Pituitary Disease
Pros and Cons of large scale screening of Cushing's syndrome
A. Themmen
Mon 26 09:25
S11.3
Symposium 11: Premature Ovarian Failure (POF)
Ovarian AMH - Implications for the diagnosis of premature ovarian failure
T. Thomas
Sun 25 09:00
S3.2
Symposium 3: Bone Cell Biology
Cross talks between Leptin and the skeleton
W. Thomas
Tue 27 16:10
S25.3
Symposium 25: Non-classical responses to hormones
Protein kinase D as a modulator of aldosterone action in the kidney
Chris Thompson
Mon 26 18:20
Satellite Symposium: Hypontraemia: is treatment necessary? An interactive forum.
Mild and moderate hyponatraemia - is treatment necessary?
Y. Tomer
Wed 28 09:00
S26.3
Symposium 26: Adverse effects of drugs on thyroid
Interferons and thyroid
J. Tomlinson
Tue 27 16:00
S23.2
Symposium 23: Obesity: clinical manifestations and therapeutic intervention
Lifestyle intervention and pharmacologic approaches to weight loss
A.K. Topaloglu
Mon 26 16:00
S17.2
Symposium 17: Genetic basis of infertility: Clinical studies and animal models
Neurokinin B signalling in human puberty
J. Toppari
Sun 25 08:45
S1.2
Symposium 1: European Networks
NECTAR - Network for Environmental Chemical Toxicants Affecting Reproduction
T. Travison
Sun 25 12:15
S4.3
Symposium 4: The Ageing Male
The natural history of symptomatic androgen deficiency in men: Longitudinal results from the Massachussets Male Aging Study
S. Tsagarakis
Tue 27 12:15
S20.3
Symposium 20: The endocrine incidentaloma
Adrenal Incidentalomas
D. Vanderschueren
Sun 25 11:45
S4.2
Symposium 4: The Ageing Male
Osteoporosis in the aging male
B. Velkeniers
Mon 26 11:55
S13.3
Symposium 13: The TSH Reference Range
A critical synopsis of current meta-analyses in the field of subclinical thyroid disease
Joseph Verbalis
Georgetown University, USA
Mon 26 19:05
Satellite Symposium: Hypontraemia: is treatment necessary? An interactive forum.
Considering new treatments in the management of hyponatraemia: Case study highlights
Georgetown University, USA
P. Vitti
Tue 27 11:15
S20.1
Symposium 20: The endocrine incidentaloma
Thyroid incidentaloma. Endocrine incidentaloma
H. Vlassara
Sun 25 16:30
S9.3
Symposium 9: The role of oxidative stress in the development of the metabolic syndrome
Marked improvement of insulin resistance by reduced AGE intake; a non-pharmacologic, non-nutrient based intervention for type 2 diabetes
H. Voelzke
Mon 26 11:15
S13.1
Symposium 13: The TSH Reference Range
Determinants of the TSH reference range
M. Vrablik
Tue 27 12:15
S21.3
Symposium 21: The cardiometabolic interface
Mechanism and treatment of diabetic dyslipidemia
S. Webb
Sun 25 09:45
S1.6
Symposium 1: European Networks
The European Registry on Cushing’s Syndrome (ERCUSYN) Database: First year experience
W. Wiersinga
Sun 25 09:00
S1.3
Symposium 1: European Networks
EUGOGO
D. Williams
Sun 25 10:15
PL1
Plenary Lecture 1
Twenty years' experience with post-Chernobyl thyroid cancer
M. Wolff
Sun 25 16:00
S7.2
Symposium 7: Approaches to preservation of gonadal function after cancer therapy
ART/IVF and cryopreservation
C. Worda
Tue 27 09:15
S18.2
Symposium 18: Diabetes in pregnancy
New treatment modalities in diabetic pregnancy
F. Wu
Sun 25 08:30
S1.1
Symposium 1: European Networks
Endocrinology of the Ageing Male – The European Male Ageing Study (EMAS)
Hannele Yki-Jarvinen
Helsinki, Finland
Sat 24 15:50
LOC Satellite Symposium: New kids on the block: Fat and Gut as Novel Targets in T2DM Treatment and Prevention
DPP-4 agonists in the treatment of type 2 diabetes mellitus
Helsinki, Finland
Workshop 0
Oral 0
Expert 0
Plenary 0
Catering and Social 0
Nurse 0
Other 0
Symposium 0
No Session Type 3
Sun 25 07:00
Satellite Symposia: Controversial Issues in Acromegaly
Faculty presentations will be based on a pre-meeting e-poll
Sponsored by Pfizer
Room: Forum Hall
Chair: Ezio Ghigo (Italy)
Tue 27 11:15
Oral Communications 5: Reproduction & Thyroid
Room: Panorama Hall
Chairs: M. Simoni (Italy) & V. Zamrazil (Czech Republic)
Tue 27 11:15
OC5.1
Oral Communications 5: Reproduction & Thyroid
Therapeutic concentrations of mitotane inhibit thyrotroph cell viability and TSH secretion in a mouse cell line model
Tue 27 11:30
OC5.2
Oral Communications 5: Reproduction & Thyroid
The influence of cure of subclinical hyperthyroidism on diastolic diameters of heart chambers and cardiac index
Tue 27 11:45
OC5.3
Oral Communications 5: Reproduction & Thyroid
Socio-economic factors and mortality in Turner syndrome – a registry study
Tue 27 12:00
OC5.4
Oral Communications 5: Reproduction & Thyroid
One hormone, two functions - The chorionic gonadotropin in New World Monkeys
Tue 27 12:15
OC5.5
Oral Communications 5: Reproduction & Thyroid
Predictive factors of intermittent ovarian function in Patients with Premature Ovarian Failure
Tue 27 12:30
OC5.6
Oral Communications 5: Reproduction & Thyroid
Universal screening detects twice more thyroid disorders in early pregnancy than targeted high-risk case finding
Tue 27 15:30
Oral Communications 6: Bone
Room: Panorama Hall
Chairs: A. Giustina (Italy) & J. Bollerslev (Norway)
Tue 27 15:30
OC6.1
Oral Communications 6: Bone
A proteomic approch to study parathyroid glands
Tue 27 15:45
OC6.2
Oral Communications 6: Bone
Association between serum osteocalcin and insulin sensitivity in primary hyperparathyroidism
Tue 27 16:00
OC6.3
Oral Communications 6: Bone
Six novel mutations in 25-hydroxyvitamin D3 1alpha hydroxylase gene in patients with pseudovitamin D deficiency rickets.
Tue 27 16:15
OC6.4
Oral Communications 6: Bone
Age-dependent features of bone mineral density changes in male rats with hyperthyroidism
Tue 27 16:30
OC6.5
Oral Communications 6: Bone
The ratio of PTH as measured by third and second generation assays as a marker for parathyroid carcinoma.
Tue 27 16:45
OC6.6
Oral Communications 6: Bone
Suppression of Circulating Fibroblast Growth Factor-23 by Cinacalcet in Patients with Primary Hyperparathyroidism

0 result(s) found.

Please wait...

     
      - 
     
     
     


    Abstracts from this event
      Abstracts from other events


          Session starts at:
          Abstract time:
        Event:


        Read full abstract